132 related articles for article (PubMed ID: 24101172)
1. Expression of estrogen receptor α and β in esophageal squamous cell carcinoma.
Dong J; Jiang SW; Niu Y; Chen L; Liu S; Ma T; Chen X; Xu L; Su Z; Chen H
Oncol Rep; 2013 Dec; 30(6):2771-6. PubMed ID: 24101172
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor α and β in esophageal squamous cell carcinoma.
Zuguchi M; Miki Y; Onodera Y; Fujishima F; Takeyama D; Okamoto H; Miyata G; Sato A; Satomi S; Sasano H
Cancer Sci; 2012 Jul; 103(7):1348-55. PubMed ID: 22463081
[TBL] [Abstract][Full Text] [Related]
3. Selective oestrogen receptor antagonists inhibit oesophageal cancer cell proliferation in vitro.
Al-Khyatt W; Tufarelli C; Khan R; Iftikhar SY
BMC Cancer; 2018 Feb; 18(1):121. PubMed ID: 29390981
[TBL] [Abstract][Full Text] [Related]
4. Characterization of serum estradiol level and tissue estrogen receptor immunostaining with clinical response and reproductive factor changes in Chinese female patients with esophageal squamous cell carcinoma.
Zhang D; Ku J; Liu R; Wu H; Liang G; Wei Y; Chen P; Zhao X; Liu S; Li Y; Yao J; Song X; Wang L
Biomed Pharmacother; 2017 Sep; 93():879-884. PubMed ID: 28724213
[TBL] [Abstract][Full Text] [Related]
5. The prognostic values of estrogen receptor alpha and beta in patients with gastroesophageal cancer: A meta-analysis.
Zhang D; Ku J; Yi Y; Zhang J; Liu R; Tang N
Medicine (Baltimore); 2019 Nov; 98(46):e17954. PubMed ID: 31725654
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters.
Wang M; Pan JY; Song GR; Chen HB; An LJ; Qu SX
Eur J Surg Oncol; 2007 Mar; 33(2):195-201. PubMed ID: 17046193
[TBL] [Abstract][Full Text] [Related]
7. Investigation of immunohistochemical ERα, ERβ and ERβcx expressions in normal and neoplastic breast tissues.
Bozkurt KK; Kapucuoğlu N
Pathol Res Pract; 2012 Mar; 208(3):133-9. PubMed ID: 22336175
[TBL] [Abstract][Full Text] [Related]
8. Vav1 expression is increased in esophageal squamous cell carcinoma and indicates poor prognosis.
Zhu X; Jin H; Xia Z; Wu X; Yang M; Zhang H; Shang X; Cheng R; Zhan Z; Yu Z
Biochem Biophys Res Commun; 2017 Apr; 486(2):571-576. PubMed ID: 28336434
[TBL] [Abstract][Full Text] [Related]
9. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract][Full Text] [Related]
10. Significance of immunohistochemical expression of estrogen receptors alpha and beta in squamous cell carcinoma of the esophagus.
Nozoe T; Oyama T; Takenoyama M; Hanagiri T; Sugio K; Yasumoto K
Clin Cancer Res; 2007 Jul; 13(14):4046-50. PubMed ID: 17634528
[TBL] [Abstract][Full Text] [Related]
11. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition.
Wang N; Liu F; Cao F; Jia Y; Wang J; Ma W; Tan B; Wang K; Song Q; Cheng Y
Cancer Biol Ther; 2015; 16(4):528-40. PubMed ID: 25719728
[TBL] [Abstract][Full Text] [Related]
12. Differential expression patterns and clinical significance of estrogen receptor-α and β in papillary thyroid carcinoma.
Huang Y; Dong W; Li J; Zhang H; Shan Z; Teng W
BMC Cancer; 2014 May; 14():383. PubMed ID: 24884830
[TBL] [Abstract][Full Text] [Related]
13. Expression and regulation of the estrogen receptors in PC-3 human prostate cancer cells.
Pisolato R; Lombardi AP; Vicente CM; Lucas TF; Lazari MF; Porto CS
Steroids; 2016 Mar; 107():74-86. PubMed ID: 26742628
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of estrogen receptor subtypes and variants in ovarian cancer: effects on cell invasion, proliferation and prognosis.
Chan KKL; Siu MKY; Jiang YX; Wang JJ; Wang Y; Leung THY; Liu SS; Cheung ANY; Ngan HYS
BMC Cancer; 2017 Aug; 17(1):606. PubMed ID: 28859612
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of microRNA-34a in esophageal squamous cell carcinoma.
Lin X; Xu XY; Chen QS; Huang C
Genet Mol Res; 2015 Dec; 14(4):17684-91. PubMed ID: 26782413
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of ERα, ERβ, and TFF1 in type I and II ovarian tumors.
Abdou AG; Aiad HA; Asaad NY; Abd El-Wahed MM; Serag El-Dien M
Appl Immunohistochem Mol Morphol; 2014 Jul; 22(6):421-32. PubMed ID: 24162262
[TBL] [Abstract][Full Text] [Related]
17. The tumor-suppressive role of BATF2 in esophageal squamous cell carcinoma.
Han T; Wang Z; Yang Y; Shu T; Li W; Liu D; Li P; Qi R; Ren Y; Li L; Liu H; Zhang S; Zhang L
Oncol Rep; 2015 Sep; 34(3):1353-60. PubMed ID: 26135942
[TBL] [Abstract][Full Text] [Related]
18. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.
Guan S; Wang C; Chen X; Liu B; Tan B; Liu F; Wang D; Han L; Wang L; Huang X; Wang J; Yao B; Shi J; Chen P; Nesa EU; Song Q; Cheng Y
Tumour Biol; 2016 Apr; 37(4):4383-91. PubMed ID: 26499784
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathological and prognostic significance of ERα and ERβ expression in lung carcinomas: a tissue microarray study].
Yang X; Xue LY; Liu Y; Guo L; Wen P; Lin DM
Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):678-83. PubMed ID: 24332055
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
He Z; Yi J; Jin L; Pan B; Chen L; Song H
Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
